Patent · US Active

Methods of identifying ActRIIB variants

US10377996B2 · kind B2 · utility

23Cited by
80References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 27, 2016
Grant dateAug 13, 2019
Priority date
Expiry dateOct 27, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.